Bought the ticket, hasn't taken the ride: the company has already paid for its next stage and is now waiting to be paid
The model's full reasoning — Q4 2022 call → NOWe need to answer YES or NO based on the transcript. The question asks: does management make clear that the company has already paid, in cash or real resources, for a stage of business it has not yet been paid back for? That is, spending done, return outstanding, and payback treated as a matter of time. Look for evidence in the transcript. Management discusses various programs, financials, and plans. Key points: They sold royalty rights to Royalty Pharma for $250M upfront plus potential $160M. They have cash and investments. They talk about 20 in '25 program. They talk about pipeline expansion. They talk about capital expenditures up to $200M in fiscal 2023 for footprint expansion including GMP manufacturing. They talk about operating cash burn $70-90M per quarter. They talk about milestones from partners. But the question is about a specific situation: already spent money or resources for a stage of business not yet paid back. For example, they are building GMP manufacturing capacity. That is capital expenditure. But is that described as already spent? They say "we expect capital expenditures up to $200 million as we near completion on our footprint expansion projects, including GMP manufacturing." That suggests they are nearing completion, but not yet fully spent? They say "as we near completion" - so spending is ongoing, not fully done. Also, the return from that manufacturing is not yet realized. But is it described as a stage of business? They are expanding manufacturing capacity for future products. But is the payback treated as a matter of time? They don't explicitly say that the manufacturing will be used to generate revenue soon. They talk about pipeline and clinical trials. Another possibility: They have invested in clinical trials. For example, they have Phase 2 studies for ARO-APOC3 and ARO-ANG3. They have spent money on those trials, and the results are in, but the revenue from those drugs is not yet realized. They are planning Phase 3 studies. But that is normal investment in R&D. The question asks for a situation where the spending is done and the return is outstanding, and management treats the payback as a matter of time. For clinical trials, the return is not guaranteed; it depends on regulatory approval, market acceptance, etc. So that is not a matter of time but a matter of luck/approval.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| RCEL | AVITA Medical, Inc. | Q1 2024 | 2024-05-14 | F |
| ERO | Ero Copper Corp. | Q1 2024 | 2024-05-10 | A |
| HCKT | The Hackett Group, Inc. | Q1 2024 | 2024-05-08 | C |
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| GOLD | Barrick Gold Corporation | Q3 2023 | 2023-11-02 | C |
| TGLS | Tecnoglass Inc. | Q2 2023 | 2023-08-08 | A |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| GVP | GSE Systems, Inc. | Q1 2023 | 2023-05-15 | D |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| SLDP | Solid Power, Inc. | Q1 2023 | 2023-05-08 | C+ |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| CEIX | CONSOL Energy Inc. | Q4 2022 | 2023-02-07 | B |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| MEC | Mayville Engineering Company, Inc. | Q3 2022 | 2022-11-05 | B+ |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLYW | Flywire Corporation | Q1 2022 | 2022-05-14 | B+ |
| IRTC | iRhythm Technologies, Inc. | Q1 2022 | 2022-05-07 | C+ |
| STC | Stewart Information Services Corporation | Q1 2022 | 2022-04-29 | C+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| ALB | Albemarle Corporation | Q3 2018 | 2018-11-08 | B |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| CP | Canadian Pacific Railway Limited | Q2 2018 | 2018-07-19 | B+ |
| ACHC | Acadia Healthcare Company, Inc. | Q4 2017 | 2018-02-22 | C+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| HTLF | Heartland Financial USA, Inc. | Q3 2017 | 2017-10-30 | B+ |
| PDCO | Patterson Companies, Inc. | Q3 2017 | 2017-02-23 | C |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| TGI | Triumph Group, Inc. | Q2 2017 | 2016-11-03 | C+ |
| RCL | Royal Caribbean Cruises Ltd. | Q1 2016 | 2016-04-29 | C+ |
PRIM · Q2 2018 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the revenue from that hasn't arrived yet. YES The transcript shows management describing the Willbros acquisition as a completed outlay: closed June 1, $165 million total paid ($38.4 million cash for shares + $123.2 million debt settlement + $3.1 million fees), net cash $111 million, funded by revolver, then refinanced 220 million term loan. This is treated as already done, not planned. The return is still largely outstanding: only one month of Willbros operations reported ($61 million revenue, $6.8 million gross profit, $2.9 million operating income in June), merger-related expenses $7.
PSX · Q4 2016 → YESThe question is about whether management describes having already spent money or resources for a larger operation, but the returns haven't come yet, and they expect them soon as a matter of time. YES Management describes the U.S. Gulf Coast Petrochemicals Project as already substantially paid for: capital spending is “reduced following the completion of the project” and “down significantly” compared with last year, with roughly $1 billion of CapEx no longer available for distribution.
TGI · Q2 2017 → YESThe question is about whether management describes having already spent money or resources for a larger operation that hasn't paid back yet. YES The transcript shows management describing a clear situation matching all three criteria. On slide 13, they report "$126 million" of year-to-date investments in development programs as a completed cash outflow ("used $126 million"), with incremental customer financing providing $100 million offset.